Miyao Y - Search Results

1

Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system.

Kishima H, Shimizu K, Miyao Y, Mabuchi E, Tamura K, Tamura M, Sasaki M, Hakakawa T. Kishima H, et al. Among authors: miyao y. Br J Cancer. 1998 Aug;78(4):446-53. doi: 10.1038/bjc.1998.513. Br J Cancer. 1998. PMID: 9716025 Free PMC article.

2

Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.

Moriuchi S, Shimizu K, Miyao Y, Hayakawa T. Moriuchi S, et al. Among authors: miyao y. Br J Cancer. 1993 Nov;68(5):831-7. doi: 10.1038/bjc.1993.441. Br J Cancer. 1993. PMID: 8217597 Free PMC article.

3

Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas.

Kishima H, Shimizu K, Tamura K, Miyao Y, Mabuchi E, Tominaga E, Matsuzaki J, Hayakawa T. Kishima H, et al. Among authors: miyao y. Br J Cancer. 1999 Jan;79(2):333-9. doi: 10.1038/sj.bjc.6690053. Br J Cancer. 1999. PMID: 9888477 Free PMC article.

4

Murine model of leptomeningeal dissemination using human medulloblastoma cells.

Yamada M, Shimizu K, Tamura K, Moriuchi S, Mabuchi E, Park KC, Miyao Y, Hayakawa T. Yamada M, et al. Among authors: miyao y. Neurol Med Chir (Tokyo). 1991 Dec;31(12):763-7. doi: 10.2176/nmc.31.763. Neurol Med Chir (Tokyo). 1991. PMID: 1726223 Free article.

5

Effects of phenytoin on cell-mediated immunity.

Okamoto Y, Shimizu K, Tamura K, Miyao Y, Yamada M, Tsuda N, Matsui Y, Mogami H. Okamoto Y, et al. Among authors: miyao y. Cancer Immunol Immunother. 1988;26(2):176-9. doi: 10.1007/BF00205612. Cancer Immunol Immunother. 1988. PMID: 3258793 Free PMC article.

6

[Effects of phenytoin on cell-mediated immunity].

Okamoto Y, Shimizu K, Tamura K, Miyao Y, Yamada M, Matsui Y, Tsuda N, Mogami H. Okamoto Y, et al. Among authors: miyao y. No To Shinkei. 1987 Oct;39(10):931-6. No To Shinkei. 1987. PMID: 3501727 Japanese.

7

Infectious retrovirus is inactivated by serum but not by cerebrospinal fluid or fluid from tumor bed in patients with malignant glioma.

Shimizu K, Miyao Y, Tamura M, Kishima H, Ohkawa M, Mabuchi E, Yamada M, Hayakawa T, Ikenaka K. Shimizu K, et al. Among authors: miyao y. Jpn J Cancer Res. 1995 Nov;86(11):1010-3. doi: 10.1111/j.1349-7006.1995.tb03013.x. Jpn J Cancer Res. 1995. PMID: 8567389 Free PMC article.

8

In vitro assessment for neurotoxicity of antitumor agents before local administration into central nervous system.

Moriuchi S, Shimizu K, Miyao Y, Yamada M, Ohkawa M, Hayakawa T. Moriuchi S, et al. Among authors: miyao y. Anticancer Res. 1996 Jan-Feb;16(1):135-40. Anticancer Res. 1996. PMID: 8615598

9

Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells.

Miyao Y, Shimizu K, Tamura M, Akita H, Ikeda K, Mabuchi E, Kishima H, Hayakawa T, Ikenaka K. Miyao Y, et al. Jpn J Cancer Res. 1997 Jul;88(7):678-86. doi: 10.1111/j.1349-7006.1997.tb00436.x. Jpn J Cancer Res. 1997. PMID: 9310141 Free PMC article.

10

Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma.

Mabuchi E, Shimizu K, Miyao Y, Kaneda Y, Kishima H, Tamura M, Ikenaka K, Hayakawa T. Mabuchi E, et al. Among authors: miyao y. Gene Ther. 1997 Aug;4(8):768-72. doi: 10.1038/sj.gt.3300478. Gene Ther. 1997. PMID: 9338004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters